Literature DB >> 11333986

Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase.

D V Bulavin1, Y Higashimoto, I J Popoff, W A Gaarde, V Basrur, O Potapova, E Appella, A J Fornace.   

Abstract

Response to genotoxic stress can be considered as a multistage process involving initiation of cell-cycle arrest and maintenance of arrest during DNA repair. Although maintenance of G2/M checkpoints is known to involve Chk1, Chk2/Rad53 and upstream components, the mechanisms involved in its initiation are less well defined. Here we report that p38 kinase has a critical role in the initiation of a G2 delay after ultraviolet radiation. Inhibition of p38 blocks the rapid initiation of this checkpoint in both human and murine cells after ultraviolet radiation. In vitro, p38 binds and phosphorylates Cdc25B at serines 309 and 361, and Cdc25C at serine 216; phosphorylation of these residues is required for binding to 14-3-3 proteins. In vivo, inhibition of p38 prevents both phosphorylation of Cdc25B at serine 309 and 14-3-3 binding after ultraviolet radiation, and mutation of this site is sufficient to inhibit the checkpoint initiation. In contrast, in vivo Cdc25C binding to 14-3-3 is not affected by p38 inhibition after ultraviolet radiation. We propose that regulation of Cdc25B phosphorylation by p38 is a critical event for initiating the G2/M checkpoint after ultraviolet radiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11333986     DOI: 10.1038/35075107

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  165 in total

1.  Activation of Cdh1-dependent APC is required for G1 cell cycle arrest and DNA damage-induced G2 checkpoint in vertebrate cells.

Authors:  T Sudo; Y Ota; S Kotani; M Nakao; Y Takami; S Takeda; H Saya
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

2.  Rapid activation of G2/M checkpoint after hypertonic stress in renal inner medullary epithelial (IME) cells is protective and requires p38 kinase.

Authors:  Natalia I Dmitrieva; Dmitry V Bulavin; Albert J Fornace; Maurice B Burg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

Review 3.  Control of the G2/M transition.

Authors:  George R Stark; William R Taylor
Journal:  Mol Biotechnol       Date:  2006-03       Impact factor: 2.695

4.  Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism.

Authors:  Katsuhiro Uto; Daigo Inoue; Ken Shimuta; Nobushige Nakajo; Noriyuki Sagata
Journal:  EMBO J       Date:  2004-07-22       Impact factor: 11.598

5.  The 5q- syndrome: biology and treatment.

Authors:  Eric Padron; Rami Komrokji; Alan F List
Journal:  Curr Treat Options Oncol       Date:  2011-12

6.  DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B.

Authors:  Stela S Palii; Beth O Van Emburgh; Umesh T Sankpal; Kevin D Brown; Keith D Robertson
Journal:  Mol Cell Biol       Date:  2007-11-08       Impact factor: 4.272

Review 7.  Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.

Authors:  H Christian Reinhardt; Michael B Yaffe
Journal:  Curr Opin Cell Biol       Date:  2009-02-21       Impact factor: 8.382

Review 8.  In vivo roles of CDC25 phosphatases: biological insight into the anti-cancer therapeutic targets.

Authors:  Hiroaki Kiyokawa; Dipankar Ray
Journal:  Anticancer Agents Med Chem       Date:  2008-12       Impact factor: 2.505

9.  Feedback control of the protein kinase TAK1 by SAPK2a/p38alpha.

Authors:  Peter C F Cheung; David G Campbell; Angel R Nebreda; Philip Cohen
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

10.  Xp38gamma/SAPK3 promotes meiotic G(2)/M transition in Xenopus oocytes and activates Cdc25C.

Authors:  Eusebio Perdiguero; Marie-Jeanne Pillaire; Jean-Francois Bodart; Florian Hennersdorf; Morten Frödin; Nicholas S Duesbery; Gema Alonso; Angel R Nebreda
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.